Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 23 10:09AM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)- Insider Own23.86% Shs Outstand5.85M Perf Week3.60%
Market Cap13.45M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float4.45M Perf Month13.86%
Income- PEG- EPS next Q- Inst Own1.07% Short Float13.48% Perf Quarter5.02%
Sales- P/S- EPS this Y- Inst Trans-28.88% Short Ratio2.32 Perf Half Y-28.79%
Book/sh4.68 P/B0.49 EPS next Y- ROA- Short Interest0.60M Perf Year65.47%
Cash/sh4.82 P/C0.48 EPS next 5Y- ROE- 52W Range1.27 - 4.62 Perf YTD10.58%
Dividend Est.- P/FCF- EPS past 5Y29.57% ROI- 52W High-50.27% Beta0.21
Dividend TTM- Quick Ratio17.60 Sales past 5Y- Gross Margin- 52W Low81.10% ATR (14)0.19
Dividend Ex-Date- Current Ratio17.60 EPS Y/Y TTM17.32% Oper. Margin0.00% RSI (14)49.40 Volatility6.88% 10.52%
Employees- Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom3.00 Target Price7.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q46.38% Payout- Rel Volume0.17 Prev Close2.26
Sales Surprise- EPS Surprise46.99% Sales Q/Q- EarningsNov 27 BMO Avg Volume258.65K Price2.30
SMA20-6.39% SMA503.13% SMA200-17.98% Trades Volume7,585 Change1.77%
Date Action Analyst Rating Change Price Target Change
Dec-05-19Initiated Dawson James Buy
Jan-11-18Reiterated H.C. Wainwright Buy $5.50 → $6
Nov-28-17Reiterated H.C. Wainwright Buy $7 → $5.50
Sep-28-17Reiterated H.C. Wainwright Buy $6 → $7
Jan-19-17Initiated Rodman & Renshaw Buy $6
Aug-01-16Reiterated Maxim Group Buy $11 → $6
May-20-16Reiterated Chardan Capital Markets Buy $6 → $4
Mar-16-16Reiterated Chardan Capital Markets Buy $7.75 → $6
Jan-19-16Reiterated Maxim Group Buy $18 → $11
Oct-09-15Initiated Maxim Group Buy $18
Mar-26-24 08:35AM
Mar-25-24 07:37PM
Dec-22-23 10:36AM
Dec-14-23 07:13PM
Dec-13-23 12:37PM
11:18AM Loading…
Dec-08-23 11:18AM
Dec-07-23 01:54PM
Dec-05-23 03:42PM
Nov-28-23 11:56AM
Nov-27-23 08:00AM
Nov-13-23 04:05PM
Nov-06-23 08:00AM
Oct-31-23 06:39PM
Oct-19-23 07:33PM
04:05PM Loading…
Oct-18-23 04:05PM
Sep-21-23 03:25PM
Aug-16-23 05:08PM
Aug-04-23 04:15PM
Jul-25-23 10:22AM
Jun-06-23 07:00AM
May-11-23 04:30PM
Mar-31-23 04:45PM
Mar-21-23 12:04PM
Nov-30-22 08:30AM
Aug-31-22 08:00AM
Jun-23-22 08:30AM
Jun-06-22 01:33PM
Jun-01-22 08:00AM
08:00AM Loading…
May-11-22 08:00AM
Apr-07-22 08:30AM
Mar-01-22 08:30AM
Feb-07-22 08:30AM
Jan-05-22 09:15AM
Dec-28-21 05:26AM
Dec-23-21 04:15PM
Nov-22-21 08:00AM
Nov-03-21 08:30AM
Nov-02-21 08:30AM
Oct-18-21 08:00AM
Sep-01-21 08:30AM
Aug-05-21 08:30AM
Jul-01-21 02:12AM
Jun-30-21 11:32AM
Jun-19-21 04:45AM
May-12-21 08:00AM
Mar-19-21 07:00AM
Mar-15-21 07:00AM
Jan-27-21 08:30AM
Jan-02-21 01:43AM
Nov-18-20 08:00AM
Aug-06-20 08:00AM
Jul-23-20 09:35AM
Jun-07-20 08:01AM
Jun-05-20 04:05PM
May-27-20 04:45PM
May-08-20 09:31PM
Apr-30-20 09:00AM
Apr-20-20 08:45AM
Apr-16-20 12:00PM
Apr-06-20 08:12AM
Mar-12-20 12:00PM
Mar-06-20 08:00AM
Dec-30-19 06:30AM
Dec-23-19 10:26AM
Dec-20-19 07:00AM
Nov-11-19 08:48AM
Nov-06-19 08:30AM
Oct-24-19 04:30PM
Sep-25-19 08:34AM
Sep-03-19 08:00AM
Aug-19-19 06:30AM
Aug-07-19 08:00AM
Jul-09-19 06:30AM
Jun-03-19 07:00AM
May-16-19 07:30AM
May-13-19 08:00AM
Apr-08-19 07:30AM
Mar-28-19 05:00PM
Mar-18-19 08:20AM
Feb-12-19 07:00AM
Feb-07-19 12:30PM
Feb-04-19 07:40AM
Dec-13-18 07:00AM
Nov-13-18 08:50AM
Nov-05-18 06:53AM
Oct-09-18 07:00AM
Sep-05-18 07:00AM
Sep-04-18 07:00AM
Aug-29-18 08:00AM
Jul-31-18 07:00AM
Jul-12-18 07:25AM
Jun-02-18 02:40PM
May-29-18 07:00AM
May-25-18 07:30AM
May-22-18 07:00AM
Check-Cap Ltd. is a clinical stage medical diagnostics company, which engages in the development of ingestible imaging capsule system for colorectal cancer screening. Its patented technology, C-Scan, is a patient-friendly preparation-free test designed to detect polyps before they may transform into cancer. The company was founded by Yoav Kimchy in 2005 and is headquartered in Isfiya, Israel.